Autism Spectrum Disorder Trial, Recruiting NCT07579494 Sponsor: Chang Gung Memorial Hospital Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07579494
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 8 and 30 who have been diagnosed with Autism Spectrum Disorder (ASD), confirmed by a specific standardised assessment called the ADOS-2
  • People whose ASD has been classified as severity level 1 or level 2 under the DSM-5 diagnostic system (meaning moderate support needs, not the highest level)
  • People who are either currently on a stable treatment plan, or whose doctor has assessed that standard treatments have not worked for them, or who have chosen not to pursue standard treatments
  • People who score 15 or above on a consent understanding questionnaire (UBACC) and can demonstrate they understand the study's goals and risks through a guided question-and-answer process

Who may not be able to join:

  • People who have or have had serious neurological conditions, particularly epilepsy, or significant vision or hearing impairments
  • People who have or have had serious ongoing health conditions such as heart disease, diabetes, or high blood pressure
  • People who have or have had a serious brain injury
  • People who have metal devices implanted in their body, such as a pacemaker or a medication pump
  • People who have or have had serious mental health conditions such as schizophrenia, bipolar disorder, or substance use disorders
  • People who are pregnant
  • People who have significant structural abnormalities in the brain, such as a growth or lesion inside the skull
  • People who have previously had brain surgery or an infection affecting the brain or spinal cord
  • People currently taking medications that are known to increase the risk of seizures
  • People who have participated in another clinical trial within the past month
  • People with damaged skin in the area of the body where the brain stimulation would be applied
  • People with multiple sclerosis
  • People with large areas of scar tissue from a previous stroke or loss of blood flow to the brain
  • People who have had sleep disturbances during brain stimulation in the past (confirm with trial site)
  • People with severe alcohol dependency
  • People currently taking anti-epileptic (anti-seizure) medications
  • People with migraines that cannot be controlled and are related to increased pressure in the brain
  • People for whom MRI scanning is not suitable, for example due to claustrophobia
  • People for whom EEG brain monitoring is not suitable (confirm with trial site)
  • People whose ASD has been classified as severity level 3 under the DSM-5 system (the highest support needs level)
  • People who currently have a diagnosis of major depressive disorder
  • People who have had thoughts of suicide within the past year
  • People currently taking tricyclic antidepressants, certain pain medications, or any other medications known to lower the threshold for seizures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 88633281200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 May 2026
Est. completion
31 July 2030

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Changes of total scores of Social Responsiveness Scale; Changes of total scores of Repetitive Behavior Scale-Revised

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov